A Randomized, Single-Blind Pilot Study to Compare the Efficacy and Cost-Effectiveness of Frovatriptan vs. Topiramate for the Prevention of Migraine.

Trial Profile

A Randomized, Single-Blind Pilot Study to Compare the Efficacy and Cost-Effectiveness of Frovatriptan vs. Topiramate for the Prevention of Migraine.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Jan 2012

At a glance

  • Drugs Frovatriptan; Topiramate
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Dec 2011 Results published in the Headache.
    • 07 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Sep 2010 Planned end date changed from 1 Sep 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top